ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb

Circulation Research - Tập 124 Số 1 - Trang 79-93 - 2019
Erik A. Blackwood1, Christoph P. Hofmann2,1,3, Michelle Santo Domingo1, Alina S. Bilal1, Anup Sarakki1, Winston T Stauffer1, Adrian Arrieta1, Donna J. Thuerauf1, Fred W. Kolkhorst1, Oliver Müller2,3, Tobias Jakobi2,3, Christoph Dieterich2,3, Hugo A. Katus2,3, Shirin Doroudgar2,3, Christopher C. Glembotski1
1From the Department of Biology, San Diego State University Heart Institute, San Diego State University, CA (E.A.B., C.H., M.S.D., A.S.B., A.S., W.S., A.A., D.J.T., F.W.K., C.C.G.)
2Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Germany (C.H., O.J.M., H.A.K., S.D.)
3German Centre for Cardiovascular Research, Partner Site Heidelberg (C.H., O.J.M., T.J., C.D., H.A.K., S.D.)

Tóm tắt

Rationale: Endoplasmic reticulum (ER) stress dysregulates ER proteostasis, which activates the transcription factor, ATF6 (activating transcription factor 6α), an inducer of genes that enhance protein folding and restore ER proteostasis. Because of increased protein synthesis, it is possible that protein folding and ER proteostasis are challenged during cardiac myocyte growth. However, it is not known whether ATF6 is activated, and if so, what its function is during hypertrophic growth of cardiac myocytes. Objective: To examine the activity and function of ATF6 during cardiac hypertrophy. Methods and Results: We found that ER stress and ATF6 were activated and ATF6 target genes were induced in mice subjected to an acute model of transverse aortic constriction, or to free-wheel exercise, both of which promote adaptive cardiac myocyte hypertrophy with preserved cardiac function. Cardiac myocyte-specific deletion of Atf6 (ATF6 cKO [conditional knockout]) blunted transverse aortic constriction and exercise-induced cardiac myocyte hypertrophy and impaired cardiac function, demonstrating a role for ATF6 in compensatory myocyte growth. Transcript profiling and chromatin immunoprecipitation identified RHEB (Ras homologue enriched in brain) as an ATF6 target gene in the heart. RHEB is an activator of mTORC1 (mammalian/mechanistic target of rapamycin complex 1), a major inducer of protein synthesis and subsequent cell growth. Both transverse aortic constriction and exercise upregulated RHEB , activated mTORC1, and induced cardiac hypertrophy in wild type mouse hearts but not in ATF6 cKO hearts. Mechanistically, knockdown of ATF6 in neonatal rat ventricular myocytes blocked phenylephrine- and IGF1 (insulin-like growth factor 1)-mediated RHEB induction, mTORC1 activation, and myocyte growth, all of which were restored by ectopic RHEB expression. Moreover, adeno-associated virus 9- RHEB restored cardiac growth to ATF6 cKO mice subjected to transverse aortic constriction. Finally, ATF6 induced RHEB in response to growth factors, but not in response to other activators of ATF6 that do not induce growth, indicating that ATF6 target gene induction is stress specific. Conclusions: Compensatory cardiac hypertrophy activates ER stress and ATF6, which induces RHEB and activates mTORC1. Thus, ATF6 is a previously unrecognized link between growth stimuli and mTORC1-mediated cardiac growth.

Từ khóa


Tài liệu tham khảo

10.1126/science.1141448

10.1152/physiol.00034.2012

10.1016/j.bbamcr.2013.03.007

10.1016/j.yjmcc.2013.09.018

10.1007/82_2017_54

10.1128/MCB.17.9.4957

10.1091/mbc.10.11.3787

10.1016/j.yjmcc.2009.02.010

10.1016/j.ccl.2016.06.002

10.1172/JCI43008

10.1161/CIRCULATIONAHA.110.977066

10.1074/jbc.M112.423640

10.1073/pnas.1301455110

10.1016/j.ajpath.2013.02.012

10.1161/CIRCRESAHA.117.311147

10.1126/science.1157535

10.1038/embor.2011.257

10.1083/jcb.201306041

10.1016/S0960-9822(03)00506-2

10.1126/scitranslmed.3006534

10.1152/ajpheart.00284.2017

10.1152/ajpheart.2001.281.3.H1104

10.1152/ajpheart.00759.2001

10.1083/jcb.201101100

10.1152/jappl.2001.90.5.1900

10.1371/journal.pone.0042297

10.1016/j.pharmthera.2010.04.005

10.1161/01.RES.0000220643.65941.8d

10.1161/01.RES.56.6.884

10.1074/jbc.M503763200

10.1161/01.CIR.0000137836.95625.D4

10.1159/000329970

10.1016/j.bbrc.2012.04.048

10.1161/HYPERTENSIONAHA.114.03811

10.1016/j.yjmcc.2012.05.005

10.1016/j.cmet.2011.01.003

10.1093/nar/gkt429

10.1016/j.devcel.2018.04.023

10.1016/S0021-9258(17)34012-7

10.1515/hsz-2016-0312

10.1016/j.cellsig.2014.05.011

10.1128/MCB.00985-10

10.1016/j.yjmcc.2008.07.016

10.1161/CIRCULATIONAHA.111.078212

10.3390/ijms141224380

10.1073/pnas.0800939105

10.1016/j.nbd.2010.08.014

10.1016/j.celrep.2015.01.014